Over the last three weeks, we have been looking at each step and the benefit of adopting the process. This week, we look at Step 4, Measure.

USP and ChP jointly host two-day meeting to strengthen cooperation.

Ralph G. Neas, president and CEO of the Generic Pharmaceutical Association, requests that Congress get involved in the support of a more competitive drug market.

A new report from The Pharmaceutical Care Management Association alleges that FDA hinders competition in the pharmaceutical industry and influences how a drug's price is calculated.

Pfizer will pay $850 million upfront and as much as $2 billion later in a deal to jointly develop one of Merck?s cancer drugs.

Grand River Aseptic Manufacturing has announced that the company executed two commercial production contracts in one day.

Avastin plus chemotherapy for the treatment of ovarian cancer increased progression-free survival by 62% compared with chemotherapy alone.

FDA issues draft guidance on rare pediatric disease priority review vouchers in accordance with FDASIA.

The transaction provides Allergan stockholders with immediate value and enhanced commercial opportunities, according to a company statement.

In response to the Ebola outbreak in West Africa, Nitritex has donated seven pallets of personal protection equipment (PPE), including disposable coveralls, aprons, and more than 200,000 gloves to protect the healthcare workers helping to save lives during this crisis.

Selected new technologies, products, and facilities from CPhI Worldwide 2014 are reviewed.

Carrying on from our weekly column to help you eliminate a number of tablet manufacturing problems and tablet tooling failures with a simple seven-step tool-care process, we look at the third step, Repair.

The agency cites deviations from CGMPs for the manufacture of APIs at the company?s Gujarat, India plant.

The Alios Biopharma acquisition strengthens J&J's infectious disease pipeline.

USP releases compendium of quality standards for compounded medicines.

ValiRx entered into a collaboration agreement with the Deutsches Krebsforschungzentrum cancer research center.

Catalent has acquired Micron Technologies, a provider of particle size engineering technologies.

Threshold Pharmaceuticals' anticancer drug TH-302 receives FDA Fast Track designation.

Celerion has expanded its laboratory capabilities in response to increasing demand for cell-based assays.

GE Healthcare and Takeda Pharmaceutical Company announced an alliance to develop therapeutic drugs in the field of hepatic fibrosis to treat various liver diseases.

AVEO enters into a research and exclusive option agreement with Ophthotech for tivozanib (AV-951) for the treatment of ocular diseases

The European Medicines Agency responds to the European Ombudsman?s letter regarding redacted documents.

Essentra has signed an agreement to acquire Clondalkin's Specialist Packaging Division for a cash consideration of approximately $455 million.

Consort announced that it has completed the acquisition of Aesica.

As the second part of this series, we look at the importance of ?assessing? the punches and dies to check their condition and how this step may help avoid any problems that may occur during tablet manufacture.

ANSM wants company data on the benefits and risks of using Avastin over Lucentis in the treatment of wet age-related macular degeneration.

Facility will provide manufacturing services for inhalation, liquids, topicals and oral solids dosage forms

Catalent Pharma Solutions announces additional packaging and storage space for highly potent and cytotocix drugs at Kansas City facility.